2019 Publications
2019 Publications
January 1, 2019 through December 31, 2019
updated 1.7.2020
- Kadry H, Wadnap S, Xu C, Ahsan F. Digital light processing (DLP) 3D-printing technology
and photo-reactive polymers in fabrication of modified-release
tablets. Eur J Pharm Sci. 2019 May 17;135:60-67.
[Epub ahead of print] - Keshavarz A, Alobaida A, McMurtry IF, Nozik-Grayck E, Stenmark KR, Ahsan F. CAR, a
homing peptide, prolongs pulmonary preferential vasodilation
by increasing pulmonary retention and reducing systemic absorption of liposomal fasudil. Mol Pharm. 2019 Jun 13. [Epub ahead of print]
- Page S, Raut S, Al-Ahmad A. Oxygen-Glucose Deprivation/Reoxygenation-Induced Barrier Disruption at the Human Blood-Brain Barrier is Partially Mediated Through the HIF-1 Pathway. Neuro-molecular Med. 2019 Mar 26. [Epub ahead of print]
- Sivandzade F., Cucullo L. Anti-diabetic countermeasures against tobacco smoke-dependent cerebrovascular toxicity: Use and effect of Rosiglitazone IJMS (accepted 8/26/2019).
- Bhalerao A, Sivandzade F., Archie S.R., Cucullo L: Public health policies on e-cigarettes. Journal of Current Cardiology Reports (in press).
- Sivandzade F., Bhalerao A., Cucullo L. Cerebrovascular and Neurological disorders: Protective Role of NRF2 Int J Mol Sci. 2019 Jul 12;20(14). pii: E3433. doi: 10.3390/ijms20143433.
- Sivandzade F, Prasad S, Bhalerao A, Cucullo L: NRF2 and NF-B interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches. Redox Biol 2019, 21:101059.
- Sivandzade F, Cucullo L: Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood-brain barrier impairment. BMC Neurosci 2019, 20(1):15.
- Sivandzade F, Bhalerao A, Cucullo L: Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe. Bio Protoc 2019, 9(1).
- Sajja RK, Cudic P, Cucullo L: In vitro characterization of odorranalectin for peptide-based drug delivery across the blood-brain barrier. BMC Neurosci 2019, 20(1):22.
- Bhalerao A, Cucullo L: Impact of tobacco smoke in HIV progression: a major risk factor for the development of NeuroAIDS and associated CNS disorders. Journal of Public Health 2019:12.
- Archie S.R., Cucullo L. Potential harmful effects of smoking cannabis: A Cerebrovascular and Neurological Perspective. Frontiers in Pharmacology (Accepted 11/15/2019).
- Dipranjan Laha, Moonmoon Deb & Hiranmoy Das (2019) KLF2 (Krüppel-like factor 2 [lung])
regulates osteoclastogenesis by modulating autophagy, Autophagy, DOI: 10.1080/15548627.2019.1596491.
(IF: 11.10) - Kanji S, Das M, Joseph M, Aggarwal R, Sharma S, Ostrowski M, Pompili VJ, Mao HQ, and Das
H. Nanofiber-expanded human CD34+ cells heal cutaneous wounds in streptozotocin-induced
diabetic mice. Scientific Reports, 2019, Jun 10;9(1):8415. doi: 10.1038/s41598-019-44932-7.
(IF 4.12) - Lustberg M, Reinbolt R, Addison D, Rupert A, Moore S, Carothers S, Suresh A, Das H,
Berger M, Ramaswamy B, Wesolowski R, Binkley P, Raman SV, and Shapiro CL. Early Detection
of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors with T2 Cardiac
Magnetic Resonance. Circulation: Cardiovascular Imaging, 2019 May;12(5):e008777. doi:
10.1161/CIRCIMAGING.118.008777.
(IF. 6.22) - Das M, Deb M, Laha D, Joseph M, Kanji S, Aggarwal R, Iwenofu H, Pompili VJ, Jarjour
W, and Das H. Myeloid Krüppel-like factor 2 critically regulates K/BxN serum-induced
arthritis. Cells 2019, 8(8), 908.
(IF: 5.66) - Das M, Laha D, Kanji S, Joseph M, Aggarwal R, Iwenofu H, Pompili VJ, Jain MK, and
Das H. Induction of Krüppel-like factor 2 reduces K/BxN serum-induced arthritis. Journal
of Cellular and Molecular Medicine, 23:1386–1395, 2019. http://doi: 10.1111/jcmm.14041.
(IF: 4.66)
- Vijayan M, Alamri FF, Al Shoyaib A, Karamyan VT, Reddy PH. Novel miRNA PC-5P-12969 in Ischemic Stroke. Mol Neurobiol. 2019 Apr 5. [Epub ahead of print]
- Reddy PH, Swerdlow RH, Culberson J, Kang D, Mitchell TL, Smith Q, Suneja S, Ory MG, Kumar S, Vijayan M, Morsy A, Arandia G, Lawrence JJ, George E, Oliver D, Pradeepkiran JA, Yin X, Reddy AP, Manczak M, Cengiz P, Karamyan VT, Kandimalla R, Kuruva CS, Willms J, Ramasubramanian B, Sawant N, Burugu D, Boles AN, Lopez V, Carrasco R, Aguirre C, Thompson S, Blackmon J, Ament C, Wang R, Stephens ER, Hoang B, Bass K, Trippier PC, Hornback C, Kottapalli P, Kottapalli KR; Center Biotechnology and Genetics Core Facility, Oddo S. Current Status of Healthy Aging and Dementia Research: A Symposium Summary. J Alzheimers Dis. 2019 May 17. [Epub ahead of print]
- Akwii RG, Sajib MS, Zahra FT, Mikelis CM. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells. 2019 May 17;8(5). pii: E471
- Hossian AKMN, Muthumula CMR, Sajib MS, Tullar PE, Stelly AM, Briski KP, Mikelis CM, Matthaiolampakis G. Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis. J Vis Exp. 2019 Mar 30;(145).
- Sajib MS, Mikelis CM. DNA Repair Response Adaptors: Novel Targets for Vasoproliferative Retinopathy? Thromb Haemost. 2019 Mar;119(3):358. Epub 2019 Jan 8.
- Zahra FT, Sajib MS, Ichiyama Y, Akwii RG, Tullar PE, Cobos C, Minchew SA, Doçi CL, Zheng Y, Kubota Y, Gutkind JS, Mikelis CM. Endothelial RhoA GTPase is essential for in-vitro endothelial functions but dispensable for physiological in-vivo angiogenesis. Sci Rep. 2019 Aug 12;9(1):11666.
- Kaushik I, Ramachandran S, Srivastava SK. CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment. Semin Cell Dev Biol. 2019 May 4. pii: S1084-9521(18)30118-6. doi: 10.1016/j.semcdb.2019.04.018. [Epub ahead of print] Review. PMID: 31054324 [PubMed - as supplied by publisher]
- Gupta N, Gupta P, Srivastava SK. Penfluridol overcomes paclitaxel resistance in metastatic breast cancer. Sci Rep. 2019 Mar 25;9(1):5066. doi: 10.1038/s41598-019-41632-0. PMID: 30911062 [PubMed - in process] Free PMC Article
- Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Cancer cells stemness: A doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 2019 Feb 26. pii: S0925-4439(19)30071-7. doi: 10.1016/j.bbadis.2019.02.019. [Epub ahead of print] Review. PMID: 30818002 [PubMed - as supplied by publisher]
- Gupta P, Gupta N, Fofaria NM, Ranjan A, Srivastava SK. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. Cancer Lett. 2019 Feb 1;442:68-81. doi: 10.1016/j.canlet.2018.10.021. Epub 2018 Oct 26. PMID: 30409762 [PubMed - in process]
- Yao HP, Feng L, Suthe SR, Chen LH, Weng TH, Hu CY, Jun ES, Wu ZG, Wang WL, Kim SC,
Tong XM, Wang MH. Therapeutic efficacy, pharmacokinetic
profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
J Immunother Cancer. 2019 Mar 14;7(1):75.
Published Book Chapters/ Editorials/ Commentaries
- Zahra FT, Choleva E, Sajib MS, Papadimitriou E, Mikelis CM. In Vitro Spheroid Sprouting Assay of Angiogenesis. Methods Mol Biol. 2019;1952:211-218. [Book Chapter]
- Kastana P, Zahra FT, Ntenekou D, Katraki-Pavlou S, Beis D, Lionakis MS, Mikelis CM, Papadimitriou E. Matrigel Plug Assay for In-Vivo Evaluation of Angiogenesis. Methods Mol Biol. 2019;1952:219-232. [Book Chapter]